Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Accuracy of large language models in answering urological questions on lower urinary tract symptoms: comparison with the EAU 2025 guidelines.

Central European journal of urology·2026

Same author

Diagnostic performance of bpMRI versus mpMRI and AI-assisted bpMRI in prostate cancer detection: a multi-reader study.

La Radiologia medica·2026

Same author

Correction: Schubert et al. Minimally Invasive Ablation Strategies for Renal Cell Carcinoma Patients Ineligible for Surgery. <i>Life</i> 2026, <i>16</i>, 73.

Life (Basel, Switzerland)·2026

Same author

The need for a dedicated surgical consent framework for robotic telesurgery: a global call to action.

Journal of robotic surgery·2026

Same author

Early Postoperative Outcomes with the Toumai<sup>®</sup> Surgical System for Robot-Assisted Radical Prostatectomy: A Prospective Comparative Study with da Vinci<sup>®</sup>.

Cancers·2026

Same author

Lifestyle Interventions in Patients in Active Surveillance for Prostate Cancer: A Systematic Review.

Journal of clinical medicine·2026

Same journal

From the 10-20 mm gray zone to a 15 mm stone size cutoff for pediatric urolithiasis management: do guidelines need revisiting? . A systematic review and meta-analysis by the EAU Section of Endourology.

Minerva urology and nephrology·2026

Same journal

The old standard still holds up: reading CREST, POTOMAC, and ALBAN in BCG-naive high-risk non-muscle-invasive bladder cancer.

Minerva urology and nephrology·2026

Same journal

YAU - RCC Spotlight: a call to action in the evolving field of renal cell carcinoma epidemiology.

Minerva urology and nephrology·2026

Same journal

Darolutamide versus abiraterone acetate-based triplets in patients with hormone-sensitive prostate cancer: real-world, head-to-head comparison from the ARON-3 study.

Minerva urology and nephrology·2026

Same journal

Enhancing ARPI therapy in HSPC: who, when and why?

Minerva urology and nephrology·2026

Same journal

Tailoring the right "MIST" for the right patient.

Minerva urology and nephrology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Aug 26, 2025

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

Pelvic lymph node dissection in prostate and bladder cancers.

Bernardo Rocco¹, Ahmed Eissa², Giorgia Gaia³

¹Department of Urology, ASST Santi Paolo e Carlo, University of Milan, Milan, Italy.

Minerva Urology and Nephrology

|October 5, 2022

Summary

This summary is machine-generated.

Pelvic lymph node dissection (PLND) is crucial for managing prostate and bladder cancers, but carries risks. This review covers metastasis patterns, imaging, nomograms, and anatomical templates for optimal PLND in urologic oncology.

More Related Videos

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

Technical Modification of the Terminal Ureter During Total Transperitoneal Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma

Technical Modification of the Terminal Ureter During Total Transperitoneal Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma

Published on: November 22, 2019

Related Experiment Videos

Last Updated: Aug 26, 2025

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

Technical Modification of the Terminal Ureter During Total Transperitoneal Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma

Technical Modification of the Terminal Ureter During Total Transperitoneal Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma

Published on: November 22, 2019

Area of Science:

Urologic Oncology
Cancer Metastasis
Surgical Pathology

Background:

Prostate and bladder cancers represent significant global health burdens.
Lymph node status is critical for cancer management and prognosis.
Pelvic lymph node dissection (PLND) is vital in urologic oncology but associated with comorbidities.

Approach:

This narrative review synthesizes recent advancements in the field.
It discusses patterns and incidence of lymph node metastasis.
The role of imaging and nomograms in patient selection for PLND is examined.

Key Points:

Understanding lymph node metastasis patterns is essential for staging and treatment.
Imaging studies and nomograms aid in identifying patients who will benefit from PLND.
Anatomical templates guide precise and effective PLND procedures.

Conclusions:

Optimizing PLND eligibility and technique can improve patient outcomes.
Further research into minimizing PLND-associated comorbidities is warranted.
This review provides a comprehensive overview for clinicians managing prostate and bladder cancer.